The number of people with susceptibility test result for rifampicin in Togo
Togo: The number of people with susceptibility test result for rifampicin was 92.42 in 2021. ◆ Volatile
Latest (2021)
92.42
Change on year
up 3.8%
World rank
61st
of 146 countries
All-time high
92.42
in 2021
All-time low
10.63
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Togo, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Togo stood at 92.42. That is the highest value across all 5 years on record.
That represents a change of up 3.8% on the previous year and up 769.4% over five years.
That places Togo 61st out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Togo, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 10.63 | — |
| 2018 | 34.34 | +223.0% |
| 2019 | 65.45 | +90.6% |
| 2020 | 89.07 | +36.1% |
| 2021 | 92.42 | +3.8% |
Togo compared with similar countries
- Togo's 92.42 is above the median for lower middle income countries, which is 78.77, 1.2× the median. (32 countries reporting)
- Togo's 92.42 is above the median for Sub-Saharan Africa, which is 61.16, 1.5× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 36.81 | 10.63 | 65.45 | 3 |
| 2020s | 90.74 | 89.07 | 92.42 | 2 |
Countries ranked near Togo
More health data for Togo
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7948 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 875 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,021 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 2.86 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0681 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Togo?
- The number of people with susceptibility test result for rifampicin in Togo was 92.42 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Togo?
- The highest recorded value was 92.42 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Togo?
- The lowest recorded value was 10.63 in 2017.
- How does Togo rank for the number of people with susceptibility test result for rifampicin?
- Togo ranks 61st out of 146 countries with data for 2021.
- Where does this Togo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).